Monoclonal antibody drugs for the treatment of multiple sclerosis and neuromyelitis optica spectrum disorder

This article provides an overview of the monoclonal antibodies available to treat patients with MS and NMOSD, including drugs that are not yet approved in Japan.

Source: Clinical and Experimental Neuroimmunology - July 26, 2022 Category: Neurology Authors: Hisashi Murata, Yasuko Sugiyama, Naoyuki Shiraishi, Keigo Kihara, Makoto Kinoshita, Tatsusada Okuno Tags: INVITED REVIEW Source Type: research